Latest Insider Transactions at Urovant Sciences Ltd. (UROV)
This section provides a real-time view of insider transactions for Urovant Sciences Ltd. (UROV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Urovant Sciences Ltd. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Urovant Sciences Ltd.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 29
2021
|
Myrtle S Potter Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
21,480
-100.0%
|
-
|
Mar 29
2021
|
Christine Ocampo PAO; CAO/Urovant Sciences,Inc. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
78,781
-100.0%
|
-
|
Mar 29
2021
|
Bryan E. Smith GC/Urovant Sciences, Inc. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
124,447
-100.0%
|
-
|
Mar 29
2021
|
Walt Johnston Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
109,139
-100.0%
|
-
|
Mar 29
2021
|
Sef Kurstjens Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
21,480
-100.0%
|
-
|
Mar 29
2021
|
James M. Hindman Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,000
-100.0%
|
-
|
Mar 29
2021
|
Ajay Bansal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
140,098
-100.0%
|
-
|
Mar 29
2021
|
Pierre Legault Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
21,480
-100.0%
|
-
|
Mar 29
2021
|
Cornelia Haag Molkenteller CMO/Urovant Sciences, Inc. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
141,348
-100.0%
|
-
|
Mar 29
2021
|
James A. Robinson Jr. PEO;CEO/Urovant Sciences, Inc. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,385
-100.0%
|
-
|
Jan 10
2021
|
James A. Robinson Jr. PEO;CEO/Urovant Sciences, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,095
-32.81%
|
$65,520
$16.11 P/Share
|
Jan 07
2021
|
Bryan E. Smith GC/Urovant Sciences, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,761
-3.68%
|
$76,176
$16.09 P/Share
|
Jan 07
2021
|
Cornelia Haag Molkenteller CMO/Urovant Sciences, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
5,810
-3.95%
|
$92,960
$16.09 P/Share
|
Jun 19
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,957
+0.02%
|
$39,656
$8.17 P/Share
|
Jun 18
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,706
+0.03%
|
$53,648
$8.21 P/Share
|
Jun 17
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,541
+0.03%
|
$52,328
$8.53 P/Share
|
Jun 14
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,144
+0.03%
|
$50,008
$7.91 P/Share
|
Jun 13
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,367
+0.03%
|
$51,569
$7.95 P/Share
|
Jun 12
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,500
+0.03%
|
$60,000
$8.3 P/Share
|
Jun 11
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,189
+0.03%
|
$57,512
$8.58 P/Share
|
Jun 10
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,500
+0.03%
|
$60,000
$8.35 P/Share
|
Jun 07
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,649
+0.03%
|
$46,543
$7.96 P/Share
|
Jun 06
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,082
+0.03%
|
$56,656
$8.0 P/Share
|
Jun 05
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,540
+0.03%
|
$52,320
$8.02 P/Share
|
Jun 04
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,500
+0.03%
|
$52,500
$7.59 P/Share
|
Jun 03
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,424
+0.02%
|
$37,968
$7.71 P/Share
|
May 31
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,071
+0.02%
|
$35,497
$7.7 P/Share
|
May 30
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,251
+0.02%
|
$58,008
$8.44 P/Share
|
May 29
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,882
+0.03%
|
$48,174
$7.55 P/Share
|
May 28
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,807
+0.02%
|
$26,649
$7.68 P/Share
|
May 24
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,796
+0.02%
|
$26,572
$7.7 P/Share
|
May 23
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,802
+0.02%
|
$33,614
$7.76 P/Share
|
May 22
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,033
+0.02%
|
$40,264
$8.06 P/Share
|
May 21
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
9,995
+0.04%
|
$99,900,025
$9995.0 P/Share
|
May 20
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.02%
|
$80,000
$8.19 P/Share
|
May 17
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,200
+0.03%
|
$43,400
$7.36 P/Share
|
May 16
2019
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,408
+0.02%
|
$32,448
$6.79 P/Share
|
Oct 01
2018
|
Viking Global Investors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,678,571
+10.55%
|
$37,499,994
$14.0 P/Share
|